Discovery Ltd
XMUN:D3H
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Discovery Ltd
XMUN:D3H
|
ZA |
|
A
|
Ascendis Pharma A/S
F:A71
|
DK |
|
Mobilicom Ltd
ASX:MOB
|
IL |
|
I
|
IFirma SA
WSE:IFI
|
PL |
|
Inhibitor Therapeutics Inc
OTC:INTI
|
US |
|
T
|
Tech World Capital Inc
OTC:KARE
|
US |
|
Intelligent Protection Management Corp
NASDAQ:IPM
|
US |
|
Encore Capital Group Inc
NASDAQ:ECPG
|
US |
|
EOG Resources Inc
NYSE:EOG
|
US |
|
N
|
Northern Trust Corp
DUS:NT4
|
US |
|
W
|
WSOL PCL
SET:WSOL
|
TH |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is D3H's stock price target?
Not Available
D3H does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Discovery Ltd?
Projected CAGR
-18%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is -18%.
What is the Net Income forecast for Discovery Ltd?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 19%.